Breaking
Crypto Stability Plan
Archive

April 2025

Browsing
Investing

FPX Nickel Announces Board and Management Changes

Investing 5 Mins Read

FPX Nickel Corp. (TSX-V: FPX) (OTCQB: FPOCF) (‘ FPX ‘ or the ‘ Company ‘) is pleased to announce the appointment of Dan Apai, P. Eng., as the Company’s Vice President, Projects effective May 1, 2025 . Mr. Apai succeeds Andrew Osterloh who will be departing his role as a Company employee on May 9, 2025 . Further, the Company is pleased to announce that Mr. Osterloh will be nominated for election as a Board member at the Company’s annual general meeting to be held on June 26, 2025 .

Martin Turenne , President and CEO of FPX stated, ‘On behalf of the Board of Directors, I would like to thank Andrew for his dedication and service to the Company. During Andrew’s tenure and under his leadership, the Company has significantly improved the development basis for the Baptiste Nickel Project, including progressing technical maturity in the areas of metallurgy, engineering, and execution planning. We are grateful for his efforts and wish him the very best going forward.’

Mr. Turenne continued, ‘I am delighted to welcome Dan to our senior management team. Dan has been a valuable contributor since he joined the Company in January 2023 as our Engineering Manager. Dan brings a wealth of knowledge from prior experience developing and commissioning multiple large-scale projects and his deep familiarity with Baptiste will ensure a smooth transition as we further advance the Project.’

‘We are very happy to welcome Andrew to the FPX Board,’ commented the Company’s Chairman, Peter Bradshaw . ‘Andrew has demonstrated exceptional leadership in progressing Baptiste through the development of the prefeasibility and refinery studies. His deep understanding of the Project and strategic insights will be a significant asset to our Board. We look forward to his contributions as a Board member to the Company’s continued success.’

Mr. Osterloh joined FPX in June 2021 , bringing with him extensive experience from project management roles at Fluor Canada and site operations positions at several notable mining projects, including Eskay Creek (that is now being redeveloped by Skeena Gold & Silver) and Huckleberry, operated by Imperial Metals, both located in British Columbia . Mr. Osterloh will be assuming the role of VP, Engineering & Construction at Skeena Gold & Silver, as the Company undertakes redevelopment of the Eskay Creek Project.

Mr. Apai, the Company’s Engineering Manager since January 2023 , has over twenty years’ mining industry experience in civil engineering and engineering management over a diverse range of projects. As Principal Civil Engineer for Fluor Canada, he led study and detailed engineering works for numerous large-scale mining projects for clients including Teck, Newmont, BHP, First Quantum, Glencore, Josemaria Resources, and Newcrest. Dan’s technical expertise includes site layout, earthworks, water management, linear facilities (i.e., roads, powerlines, pipelines), and water supply systems – all elements that strongly influence the capital intensity, permitability, and operability of mining projects. Mr. Apai is a Member of the Association of Professional Engineers of British Columbia and holds a Bachelor of Engineering from the University of Western Australia .

About the Baptiste Nickel Project

The Company’s Baptiste Nickel Project represents a large-scale greenfield discovery of nickel mineralization in the form of a sulphur-free, nickel-iron mineral called awaruite (Ni 3 Fe) hosted in an ultramafic/ophiolite complex. The absence of sulphur and our ability to connect to the BC Hydro grid means that Baptiste has the potential to be one of the lowest carbon-intensive nickel producers in the world and will produce a very high grade product that does not required any intermediate smelting or complex refining. The Baptiste mineral claims cover an area of 453 km 2 west of Middle River and north of Trembleur Lake, in central British Columbia . In addition to the Baptiste Deposit itself, awaruite mineralization has been confirmed through drilling at several target areas within the same claims package, most notably at the Van Target which is located 6 km to the north of the Baptiste Deposit. Since 2010, approximately US$55 million has been spent on the exploration and development of Baptiste.

FPX has conducted mineral exploration activities to date subject to the conditions of agreements with First Nations and keyoh holders.

About FPX Nickel Corp.

FPX Nickel Corp. is focused on the exploration and development of the Baptiste Nickel Project, located in central British Columbia , and other occurrences of the same unique style of naturally occurring nickel-iron alloy mineralization known as awaruite. For more information, please view the Company’s website at https://fpxnickel.com/ or contact Martin Turenne , President and CEO, at (604) 681-8600 or ceo@fpxnickel.com .

On behalf of FPX Nickel Corp.

‘Martin Turenne’
Martin Turenne , President, CEO and Director

Forward-Looking Statements

Certain of the statements made and information contained herein is considered ‘forward-looking information’ within the meaning of applicable Canadian securities laws. These statements address future events and conditions and so involve inherent risks and uncertainties, as disclosed in the Company’s periodic filings with Canadian securities regulators. Actual results could differ from those currently projected. The Company does not assume the obligation to update any forward-looking statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE FPX Nickel Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2025/29/c3955.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
Investing

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Investing 6 Mins Read

Former Chief Medical Officer of Eli Lilly brings more than thirty years of pharmaceutical industry experience

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announced that pharmaceutical industry veteran Timothy J. Garnett, M.D., has been nominated to stand for election to the Company’s Board of Directors at its 2025 Annual General Meeting of shareholders to be held on May 28, 2025.

Dr. Garnett is a distinguished pharmaceutical industry executive with over 30 years’ experience, including two decades at Eli Lilly and Company, where he served as Chief Medical Officer from 2008 until his retirement in 2021. During his tenure at Eli Lilly, he led the successful development of therapeutics in women’s health, endocrinology, and neuroscience, resulting in multiple global commercial launches. Dr. Garnett has played a key role in the successful development of numerous drugs across both early- and late-stage clinical development. He has broad experience leading clinical development, portfolio management, medical affairs, regulatory strategy, and safety functional areas, and has a strategic understanding of the evolving metabolic therapy landscape.

‘We are pleased to nominate Dr. Garnett for election to our Board of Directors, as we mark a significant milestone with the recent initiation of patient enrollment in our pivotal Phase III MAVERIC trial,’ stated Guillermo Torre-Amione, M.D., Ph.D., Chair of Cardiol Therapeutics. ‘Dr. Garnett brings a wealth of industry experience and strategic vision, along with exceptional expertise in clinical development. His proven track record in guiding several drugs through regulatory approval and successful commercial launch will be instrumental in achieving our goal of making a meaningful difference for people living with underserved heart disease.’

Dr. Garnett currently serves as Chair of Ophirex and a Director of MapLight Therapeutics. In addition, he is a member of the Advisory Panel of Cambridge Innovation Capital and an equity partner at Recode Health Ventures LLC. Dr. Garnett holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from St. George’s, University of London. He is a Fellow of both the Faculty of Pharmaceutical Medicine (FFPM), and the Royal College of Obstetricians and Gynaecologists (FRCOG).

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead small molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.

Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration (‘US FDA’) to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart: recurrent pericarditis and acute myocarditis. The MAVERIC Program in recurrent pericarditis, an inflammatory disease of the pericardium which is associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, and results in physical limitations, reduced quality of life, emergency department visits, and hospitalizations, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing Phase III MAVERIC trial (NCT06708299). The ongoing ARCHER trial (NCT05180240) is a Phase II study in acute myocarditis, an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in people less than 35 years of age. The US FDA has granted Orphan Drug Designation to CardiolRx for the treatment of pericarditis, which includes recurrent pericarditis.

Cardiol is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure – a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.

For more information about Cardiol Therapeutics, please visit cardiolrx.com.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward-looking information contained herein may include, but is not limited to statements regarding the Company’s focus on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, the Company’s intended clinical studies and trial activities and timelines associated with such activities, including the Company’s plan to complete the Phase III study in recurrent pericarditis with CardiolRx, and the Company’s plan to advance the development of CRD-38, a novel subcutaneous formulation of cannabidiol intended for use in heart failure. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Information Form filed with the Canadian Securities Administrators and U.S. Securities and Exchange Commission on March 31, 2025, available on SEDAR+ at sedarplus.ca and EDGAR at sec.gov, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements and are encouraged to read the Supplement, the accompanying Base Prospectus and the documents incorporated by reference therein.

For further information, please contact:
Trevor Burns, Investor Relations +1-289-910-0855
trevor.burns@cardiolrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250087

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
Crypto news

Rumble Crypto Wallet: CEO Chris Pavlovski Reveals Launch Date with Tether CEO Backing

Crypto news 3 Mins Read

Rumble Crypto Wallet:- The Canada-based video sharing platform, Rumble, is set to foray into the crypto wallet segment.

Deemed as the YouTube alternative in Canada, the video sharing platform’s CEO Chris Pavlovski announced this entry on March 25, 2025.

Now in the latest update coming from the CEO Pavlovski, he has revealed the time for the anticipated crypto wallet launch.

In a X post on Monday, he called Rumble Wallet “as one the most ambitious projects” the firm is taking. Highlighting the collaboration with USDT Issuer, Tether, he said the wallet will launch later this year in US.

Rumble Wallet Poised to Top Charts, Says Tether CEO

Soon after announcing the launch time, Tether CEO Paolo Ardaino appreciated and provided his backing. He said in a X post that in a very short amount of time, the crypto wallet of rumble is bound to become the top Bitcoin and stablecoin wallet in US.

CEO Paulo’s backing comes as his largest stablecoin issuer firm, Tether invested $775 million in Rumble last year. The firm now owns 20–25% of stake in the video platform Rumble.

It is also worth noting that the soon to be launched Rumble Crypto Wallet is not only integrating USDT transactions but is launching the whole project in partnership with Tether.

Rumble CRO Chris Pavlovski highlighted this explicitly in his Monday X post. He declared, “This is a Rumble + Tether partnership.”

Further, Tether’s competitor and the USDC issuer Circle has received major regulatory milestone in Abu Dhabi.

What the launch of This Crypto Wallet Mean for Creators

Rumble presents its Crypto Wallet as the wallet for video creators. It says that it is designed to let content creators receive and manage digital assets directly on the Rumble ecosystem.

It is built directly into the Rumble user interface allowing creators to link their wallet balances to their partner accounts for instant withdrawals.

This is to bypass traditional ad-revenue models and payment intermediaries. Traditional ad-revenue systems take days (or weeks) to settle transactions and often depend on slow bank rails or third-party processors. With USDT on Rumble Crypto Wallet, creators can receive funds immediately anywhere in the world, 24/7.

This becomes all the more beneficial for creators as bank transfer fees, currency conversion costs, and platform commissions eat up 10–30% of a creator’s revenue. But with USDT-enabled Rumble Crypto wallet, it means that more of each dollar could stay in the creator’s pocket, boosting real take-home income.

CEO Chris says, ” I believe it will revolutionize the creator economy.” Rumble Crypto Wallet aims to serve as the vehicle for creators to help them monetize better than most advertisers, especially in international markets.

According to the World Population Review’s CPM Rates by Country 2025, United States has one of the very highest globally. For a creator, it has a YouTube CPM of $32.75 per 1,000 views.

This is high in par with other countries. The same dataset lists Uganda at $2.22 and Colombia around $4.94. Other Sub-Saharan African and Latin American countries commonly fall in that $2–$5 range.

Thus, the launch of Rumble crypto wallet means no banking cut-offs, no geo-restrictions, and no multi-day holds for creators.

 

Also Read: Clesius CEO Faces Jail!

The post Rumble Crypto Wallet: CEO Chris Pavlovski Reveals Launch Date with Tether CEO Backing appeared first on CoinGape.

Keep Reading
Crypto news

Tesla Stock Price Reclaims Uptrend After Earnings Report Crash, Here’s When to Buy, Per Experts

Crypto news 3 Mins Read

Elon Musk’s Tesla stock price faced a slump in the last few days, as the earnings report highlights a significant drop. As the stock and crypto markets had crashed earlier, the impact was significant on Tesla’s Bitcoin holding, affecting their earnings. However, with new updates and investors’ settled sentiments, the TSLA price is rising again. Time to buy? Let’s discuss.

Tesla Stock Price Settles After Earnings Report

The Tesla stock price has been down nearly 27% in YTD, and the primary stimulus is Tesla’s 71% drop in the Q1 net income, according to CNN. The Tesla earnings report reveals that the company only managed a profit due to the sale of $595M in regulatory credit, not cars.

More importantly, the Gross automotive profit margin dropped to its lowest since 2012, concerning stock investors. The TSLA stock price hit bottom at $221.86 in early April due to macroeconomic events, and again crashed to $227.50 amid the earnings report.

However, the stock has recovered significantly as Elon Musk plans to exit D.O.G.E. (Department of Government Efficiency). This decision was made concerning the performance of the company and the constant allegations that Musk was using D.O.G.E. to avoid legal issues.

Experts anticipate that Tesla is in serious trouble, but Musk denies the claims, stating, “We’re not on the ragged edge of death.”

Although he has admitted that there are challenges, he remains optimistic. Additionally, the Airbnb co-founder and Tesla board member Joe Gebbia has purchased 4,000 shares of Tesla, making it the first insider purchase since 2020.

This suggests increasing confidence in the company. Due to these events, the TSLA stock price regained some uptrend, currently worth $285.88. Many crypto stock prices are also attempting to recover amid improving macroeconomic events.

Tesla Stock Price News: When to Buy?

In these ups and downs, some investors are seeing a buying opportunity. One such crypto expert presented the timelines on when to sell and when to buy. According to StrengthPlan, the investors can consider buying once the Tesla stock price reaches $222 in May.

At that time, it would act as a local bottom retest, providing the right opportunity. The post also mentioned the stock reaching the same local bottom in January 2026, acting as a buying opportunity.

At the same time, it mentioned $465 as the all-time rejection zone, i.e., the stimulus to sell. Interestingly, the next selling point is $645 once it hits a new ATH.

Overall, the expert’s analysis forecasts a potential TSLA price crash in May 2025 and a new ATH in summer 2026.

The post Tesla Stock Price Reclaims Uptrend After Earnings Report Crash, Here’s When to Buy, Per Experts appeared first on CoinGape.

Keep Reading
Crypto news

Nasdaq Files S-1 For 21Shares Dogecoin ETF With SEC

Crypto news 2 Mins Read

Nasdaq has submitted an S-1 form for the 21Shares Dogecoin ETF with the US Securities and Exchange Commission (SEC). This move officially kicks off the approval process, with the Commission having to decide whether or not to approve the fund, which will provide institutional investors access to the top meme coin.

Nasdaq Files To List & Trade 21Shares Dogecoin ETF

A Nasdaq filing has revealed that the exchange has submitted an application to the US SEC to list and trade the 21Shares Dogecoin ETF. This move is significant, as the S-1 filing officially begins the approval process.

The SEC will then move to publish the filing in the Federal Register and ask for public comments on the filing before it decides to approve or deny. It is worth mentioning that asset manager 21Shares had earlier this month filed the 19b-4 form for its DOGE ETF. This move showed the firm’s intention to offer investors exposure to the largest meme coin by market cap.

Besides 21Shares, Grayscale, and Bitwise have also filed to offer a Dogecoin ETF, providing a bullish outlook for the DOGE price, which could surge as institutional investors invest in the meme coin. More asset managers are expected to file for a DOGE ETF as interest in the meme coin picks up.

What’s Next For The Dogecoin Price?

The DOGE price remained unchanged following Nasdaq’s S-1 filing for the 21Shares Dogecoin ETF. However, crypto analyst Trader Tardigrade predicts that a breakout might be on the horizon for the top meme coin.

In an X post, the analyst noted that Dogecoin has been moving within different ranges, experiencing both false breakdowns and breakouts. He added that the meme coin has now returned to its current range. In line with this, he expects DOGE to break out, potentially sending it higher.

The post Nasdaq Files S-1 For 21Shares Dogecoin ETF With SEC appeared first on CoinGape.

Keep Reading
Crypto news

Bitcoin Cash Price Soars 21%: Will The Rally Sustain?

Crypto news 3 Mins Read

Bitcoin Cash price has spiked by 21% over the last day on the back of a raft of positives. While chatter over the sustainability of the rally has grown louder, Javon Marks is predicting an even bigger surge for Bitcoin Cash (BCH).

Bitcoin Cash Price Spikes By Over 21% Driven By Impressive Fundamentals

According to CoinMarketCap data, Bitcoin Cash price soared by over 21% in the last 24 hours to reach a high of $376.79. The sudden price surge saw BCH trading volumes climb to $373 million, a 50% increase over the last day.

A closer look at the charts and on-chain data reveals the triggers for the jolt in Bitcoin Cash price. Right out of the bat, the biggest needle-mover for BCH appears to be from its derivatives data, with rising Open Interest figures climbing by 8.76%.

Alongside the increase in the number of unsettled contracts is a surge in daily active addresses for Bitcoin Cash. The daily active addresses have risen by 5.7% over the last day, making Bitcoin Cash the highest gainer among the top 20 cryptocurrencies by market capitalization.

It appears that the exchange outflow for BCH is spiking, serving as an additional confirmation of the bullish sentiments. However, concerns over the long-term sustainability of the BCH price rally are weighing on the minds of investors.

Since racking up the 21% daily gains, the price of BCH has fallen to $372%, leaving investors scanning the horizon for the earliest signs of a correction.

Javon Marks Predicts A Longer Price Surge For BCH

Cryptocurrency analyst Javon Marks is projecting an even bigger and sustained rally for Bitcoin Cash price. In an X post, Marks theorizes that the recent gains notched by BCH are early “signs of recovery,” noting that a 300% rally is in the offing.

The crypto analyst is pegging his prediction on BCH’s soaring trading volumes and price performance to breach a falling trendline. According to Marks, on-chain data suggests that Bitcoin Cash price can reach $1,509 in this window, a 301% increase from its present levels. The analyst has previously tipped a 260% rally for Cardano price based on an ascending triangle pattern and rising long-term holding behaviour.

“With prices also still being broken out, this surge can be part of an over 300% uphill run to the $1,509.89 target,” said Marks.

While Bitcoin Cash price is tipped for a rally, Bitcoin is targeting $106K if prices break through the critical resistance of $94,200.

The broader cryptocurrency market did not match Bitcoin Cash’s recent gains, falling by 0.54% to settle at a market capitalization of just under $3 trillion.

The post Bitcoin Cash Price Soars 21%: Will The Rally Sustain? appeared first on CoinGape.

Keep Reading
Crypto news

Binance Reveals Major Update For SIGN Amid Major Listings

Crypto news 3 Mins Read

Cryptocurrency exchange titan Binance has once again captured substantial investor attention with its latest update on the SIGN token. On Tuesday, April 29, the CEX enhanced its offerings for the token’s futures listing in tandem with a 30% price rally. Now, traders and investors are left speculating if the token could sustain such a massive pump, as other renowned exchanges have also extended market support to the same.

Binance Issues Update On SIGN Token: Details

According to an official Binance release dated April 29, the CEX giant is increasing the funding rate settlement frequency of the USD-Margined SIGNUSDT Perpetual Contract from every four hours to one hour starting from April 29 at 10:00 UTC. Mentioned below are some of the other vital details that traders should know regarding this enhanced offering.

Source: Binance official site.

As per the announcement, this decision by the exchange comes primarily to protect users and prevent risks, given the highly unpredictable nature of digital assets. Further, the top crypto exchange also revealed that it may take additional protective measures in regard to the USD-Margined perpetual contract without further announcement, bringing changes to it.

The exchange added that it remains poised to make potential adjustments to the perp contract ahead, encompassing but not limited to changes in the maximum leverage value, position value, and other trade offerings. Users can move on to the official site for further details on the enhanced offerings.

SIGN Price Rallies Amid Support From Major CEXs

At the time of reporting, SIGN token price gained nearly 32% and was sitting at $0.1030. The crypto embarked upon a rally from a bottom of $0.06727 intraday. Notably, the bullish price trajectory comes riding the back of major exchange listings recently.

Not long ago, CoinGape Media reported that Binance revealed an airdrop event for SIGN and opened trading for the same. Moreover, the exchange also launched a SIGNUSDT futures listing recently.

On the other hand, even S. Korean exchange Upbit added the same token on its platform today, pegged to KRW, BTC, and USDT. Besides, even Asian crypto exchange OKX added the SIGNUSDT perpetual contract to its stockpile of offerings. Additionally, KuCoin revealed that the SIGN token went live for trading on the platform yesterday.

In response, broader market sentiments about the crypto’s future price action remain highly bullish in the wake of listings on top crypto exchanges. For context, listings on globally leading exchanges usually pave the way for increased investor interaction with assets, thereby bringing a surge of funds.

The post Binance Reveals Major Update For SIGN Amid Major Listings appeared first on CoinGape.

Keep Reading
Business

On air, ’60 Minutes’ reporter says ‘none of us is happy’ about changes that led top producer to quit

Business 2 Mins Read

“60 Minutes” correspondent Scott Pelley paid tribute Sunday to Bill Owens, the show’s executive producer who resigned last week, saying on the air that “none of us is happy” about the extra supervision that corporate leaders are imposing.

Pelley made his comments at the end of the evening’s CBS News telecast, saying that in quitting, Owens proved he was the right person for the job.

“It was hard on him and it was hard on us,” Pelley said. “But he did it for us — and you.”

His on-air statement was an unusual peek behind the scenes at the sort of inner turmoil that viewers seldom get the opportunity to see.

Owens, only the third top executive in the 57-year history of television’s most influential newscast, resigned last week, saying he no longer felt he had the independence to run the program as he had in the past, and felt necessary.

CBS News’ parent company, Paramount Global, is in the midst of a merger with Skydance Media that needs the approval of the Trump administration. Trump has sued “60 Minutes” for $20 billion, saying it unfairly edited a Kamala Harris interview last fall to her advantage. Owens and others at “60 Minutes” believe they did nothing wrong and have opposed a settlement.

As a result, Pelley explained to viewers on Sunday, Paramount has begun to supervise “60 Minutes” stories in new ways. Former CBS News President Susan Zirinsky, a longtime news producer, has reportedly been asked to look at the show’s stories before they air.

“None of our stories has been blocked,” Pelley said. “But Bill felt he lost the independence that honest journalism requires. No one here is happy about it. But in resigning, Bill proved he was the right person to lead ‘60 Minutes’ all along.”

Despite this, “60 Minutes” has done tough stories about the Trump administration almost every week since the inauguration in January, many of them reported by Pelley. On Sunday, “60 Minutes” correspondent Sharyn Alfonsi had the latest, interviewing scientists about cutbacks at the National Institutes for Health.

Trump was particularly angered by the show’s telecast two weeks ago, saying on social media that CBS News should “pay a big price” for going after him.

This post appeared first on NBC NEWS

Keep Reading
Business

IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing

Business 2 Mins Read

International Business Machines Corporation on Monday announced it will invest $150 billion in the U.S. over the next five years, including more than $30 billion to advance American manufacturing of its mainframe and quantum computers.

“We have been focused on American jobs and manufacturing since our founding 114 years ago, and with this investment and manufacturing commitment we are ensuring that IBM remains the epicenter of the world’s most advanced computing and AI capabilities,” IBM CEO Arvind Krishna said in a release.   

The company’s announcement comes weeks after President Donald Trump unveiled a far-reaching and aggressive “reciprocal” tariff policy to boost manufacturing in the U.S. As of late April, Trump has exempted chips, as well as smartphones, computers, and other tech devices and components, from the tariffs.

IBM said its investment will help accelerate America’s role as a global leader in computing and fuel the economy. The company said it operates the “world’s largest fleet of quantum computer systems,” and will continue to build and assemble them in the U.S., according to the release.

IBM competitor Nvidia, the chipmaker that has been the primary benefactor of the artificial intelligence boom, announced a similar push earlier this month to produce its NVIDIA AI supercomputers entirely in the U.S. 

Nvidia plans to produce up to $500 billion of AI infrastructure in the U.S. via its manufacturing partnerships over the next four years.

Last week, IBM reported better-than-expected first-quarter results. The company said it generated $14.54 billion in revenue for the period, above the $14.4 billion expected by analysts. IBM’s net income narrowed to $1.06 billion, or $1.12 per share, from $1.61 billion, or $1.72 per share, in the same quarter a year ago.

IBM’s infrastructure division, which includes mainframe computers, posted $2.89 billion in revenue for the quarter, beating expectations of $2.76 billion.

The company announced a new z17 AI mainframe earlier this month.

CNBC’s Jordan Novet contributed to this report.

This post appeared first on NBC NEWS

Keep Reading